Biomarker (BM) evaluations in the phase III AVAglio study of bevacizumab (Bv) plus standard radiotherapy (RT) and temozolomide (T) for newly diagnosed glioblastoma (GBM).
Ryo Nishikawa
Consultant or Advisory Role - Roche
Frank Saran
Consultant or Advisory Role - Roche
Warren Mason
Consultant or Advisory Role - Roche
Wolfgang Wick
Consultant or Advisory Role - Lilly; Roche
Honoraria - MSD; Roche
Research Funding - Apogenix; Boehringer Ingelheim; MSD
Timothy Francis Cloughesy
Consultant or Advisory Role - Apogenics; Celgene; Genentech; Merck; Merck Serono; NewGen Therapeutics; Roche; Tocagen
Roger Henriksson
Consultant or Advisory Role - Roche
Honoraria - Roche
Magalie Hilton
Employment or Leadership Position - Roche
Josep Garcia
Employment or Leadership Position - Roche
Tobias Vogt
Employment or Leadership Position - Genentech
Stock Ownership - Roche
Celine Pallaud
Employment or Leadership Position - Roche
Stock Ownership - Roche
Oliver L. Chinot
Consultant or Advisory Role - Roche
Honoraria - AstraZeneca; MSD; Roche
Research Funding - Merck; Roche